Basetwo has raised $11.5 million in Series A funding to develop its Physics AI platform, which optimizes manufacturing processes in the pharmaceutical and chemical sectors.

Target Information

Basetwo is an innovative company focused on developing an AI copilot specifically designed for manufacturing engineers, supported by Abu Dhabi's Hub71 initiative. The company has recently secured $11.5 million in Series A funding, led by AVP, with participation from existing investors including Glasswing Ventures, Deloitte Ventures, Global Brain Ventures, Shimadzu Corporation, and Chiyoda Corporation, alongside prominent angel investors from the UAE. The funding will aid Basetwo in its mission to transform how pharmaceutical and chemical manufacturers optimize their production processes.

Industry Overview

The pharmaceutical and chemical manufacturing sectors are currently grappling with significant challenges as they scale production from laboratory to commercial levels and strive to enhance existing processes for maximum quality and efficiency. Launching new drug compounds and chemical formulations necessitates precise control over numerous production parameters, including reactor temperatures and mixing speeds, while adhering to stringent quality standards.

At the commercial production stage, manufacturers must consistently assess performance, identify issues, and implement corrective actions to guarantee optimal batch quality. Traditional machine learning techniques, heavily reliant on h